NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PharMolix

PharMolix

Private
BeijingHealthcare & Life Scienceshttps://pharmolix.com/zh

Last Round

Seed

Aug 14, 2024

Company Overview

PharMolix is a biotechnology company that develops AI-powered foundation models and conversational assistants for the biomedical and drug discovery industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Foundation

Keywords

drug discoveryfoundation modelsprotein designmolecular modelingfrontier ai labbiomedical aiai drug discoverymolecular dockingmultimodal modelsbiotech aiprotein engineeringai research platformin silico drug designbiomedical signal analysisai model api

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharMolix Comps

Public and private peers based on sector, stage, and business model.

PharMolix comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PharMolix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 14, 2024
AngelAug 14, 2024

PharMolix Investors

Notable investors and investment history

PharMolix investors
InvestorRounds
Dalton VentureAngel
WestSummit CapitalAngel
讯飞创投Angel

PharMolix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharMolix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharMolix's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range6
Year Founded2023
Last FundingAug 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.